CSIMarket
 
Generation Bio Co   (NASDAQ: GBIO)
 

Generation Bio Co's Customers Performance

GBIO



 
GBIO's Source of Revenues During the corresponding time, Generation Bio Co saw a revenue deteriorated by -78.9 % year on year, sequentially revenue grew by 108.37 %. While revenue at the Generation Bio Co 's corporate clients

List of GBIO Customers




for the same period Generation Bio Co revnue deteriorated by -78.9 % year on year, sequentially revenue grew by 108.37 %.

List of GBIO Customers

Generation Bio Co's Business Units
Single Reportable Segment    100 % of total Revenue






Generation Bio Co's Comment on Sales, Marketing and Customers



The company's customers are entities subject to healthcare laws and regulations, including fraud and abuse laws, anti-kickback statutes, false claims laws, patient privacy laws, and other healthcare regulations. These laws affect business and financial arrangements, particularly those involving federal healthcare programs such as Medicare and Medicaid. The market served includes manufacturers of drugs, devices, biologics, and medical supplies who must comply with transparency requirements like the Physician Payments Sunshine Act. The healthcare market is influenced by cost containment trends and legislative changes, including the Patient Protection and Affordable Care Act (PPACA) and the American Taxpayer Relief Act of 2012, which impact coverage, reimbursement, and payment for drug products under government healthcare programs.





Generation Bio Co’s Comment on Sales, Marketing and Customers


The company's customers are entities subject to healthcare laws and regulations, including fraud and abuse laws, anti-kickback statutes, false claims laws, patient privacy laws, and other healthcare regulations. These laws affect business and financial arrangements, particularly those involving federal healthcare programs such as Medicare and Medicaid. The market served includes manufacturers of drugs, devices, biologics, and medical supplies who must comply with transparency requirements like the Physician Payments Sunshine Act. The healthcare market is influenced by cost containment trends and legislative changes, including the Patient Protection and Affordable Care Act (PPACA) and the American Taxpayer Relief Act of 2012, which impact coverage, reimbursement, and payment for drug products under government healthcare programs.








GBIO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Generation Bio Co 35.97 15.27 -62.63 115
SUBTOTAL 0.00 0.00 0.00 -

Sources: Generation Bio Co’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Generation Bio Co’s corporate clients.
For your research, we’ve provided 9 tables on Generation Bio Co corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.